1 DAVID WILLIAM CHRISTIANSON Roy and Diana Vagelos ...
1 DAVID WILLIAM CHRISTIANSON Roy and Diana Vagelos ...
1 DAVID WILLIAM CHRISTIANSON Roy and Diana Vagelos ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Business Media:<br />
<strong>DAVID</strong> <strong>WILLIAM</strong> <strong>CHRISTIANSON</strong><br />
RESEARCH COMMENTS AND HIGHLIGHTS<br />
Arginetix, Inc. Completes $2.3 Million Initial Financing <strong>and</strong> Technology License".<br />
Fiercebiotech.com, 23 October 2008. Web archive: http://www.fiercebiotech.com/pressreleases/arginetix-inc-completes-2-3-million-initial-financing-<strong>and</strong>-technology-license.<br />
"Arginetix Advances Preclinical Arginase Inhibitors for PAH, ED", by Trista Morrison.<br />
BioWorld Today, 12 February 2009, page 1.<br />
"Arginetix Closes $10.75 Million Series A Financing", by Kristy DelMuto. BioSpace.com, 2<br />
October 2009. Web archive: http://www.biospace.com/news_story.aspx?NewsEntityId=157872.<br />
"Baltimore's Arginetix Merges with Immune Control Inc. to form Corridor Pharmaceuticals" by<br />
Gus Sentementes. Baltimore Sun, 17 June 2010. Web archive:<br />
http://weblogs.baltimoresun.com/news/technology/2010/06/maryl<strong>and</strong>_biotech_merger.html.<br />
"Immune Control Taken Over by Baltimore Firm in $15M Deal", by Joseph DiStefano.<br />
Philadelphia Inquirer, 17 June 2010. Web archive: http://www.philly.com/philly/blogs/inqphillydeals/Immune_Control_taken_over_by_Baltimore_firm_in_15M_deal.html.<br />
19
Change language